Site updated at Wednesday, 22 June 2016

Living with Dementia

Amyloid Targeting Treatment

Beta secretase inhibitors to treat Alzheimer’s disease

With each new amyloid-targeting treatment for Alzheimer’s disease that has been developed, there has been a corresponding concern. For example, antibodies targeting amyloid-β peptide (Aβ) produce inflammation in the brain in some patients. Gamma secretase inhibitors tend to produce adverse effects by interacting with Notch, an important pathway for cellular signaling.

Beta secretase 1… Beta secretase inhibitors to treat Alzheimer’s disease   

Enid and George - Life with dementia

parkinson's patients5 - apoplectic dementia1 - risk of alzheimer's3 - healthy diet1 - lrp61 - psychometrics1 - α-synuclein protein2 - solanezumab1 - apoe gene3 - alzheimer's population1 - elderly people1 - degenerative brain disease1 - parkinson's diseases1 - high-dose chemotherapy1 - down syndrome2 - amyloid beta 42 peptide1 - early symptoms of alzheimer’s disease1 - stroke9 - latin dementia1 - uncategorized1 - atherosclerotic plaques2 - lewy bodies2 - executive function1 - behavioral problems1 - ruth sutherland1 - immune system1 - dementia causes3 - mci7 - undertreatment of dementia1 - physical function1 -